Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia

We read the impressive review article “Clozapine resistant schizophrenia: Newer avenues of management” with great enthusiasm and appreciation. The author believes that preventing clozapine resistance from developing may be the most effective treatment strategy for patients with clozapine-resistant s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Ping-Tao, Chen, Mu-Hong, Liang, Chih-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476841/
https://www.ncbi.nlm.nih.gov/pubmed/36158309
http://dx.doi.org/10.5498/wjp.v12.i8.1102
_version_ 1784790226165563392
author Tseng, Ping-Tao
Chen, Mu-Hong
Liang, Chih-Sung
author_facet Tseng, Ping-Tao
Chen, Mu-Hong
Liang, Chih-Sung
author_sort Tseng, Ping-Tao
collection PubMed
description We read the impressive review article “Clozapine resistant schizophrenia: Newer avenues of management” with great enthusiasm and appreciation. The author believes that preventing clozapine resistance from developing may be the most effective treatment strategy for patients with clozapine-resistant schizophrenia (CRS), and optimizing clozapine treatment is a key component. Disentangling the differences between treatment-resistant schizophrenia and CRS is important for studies addressing treatment strategies for these difficult-to-treat populations.
format Online
Article
Text
id pubmed-9476841
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-94768412022-09-23 Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia Tseng, Ping-Tao Chen, Mu-Hong Liang, Chih-Sung World J Psychiatry Letter to the Editor We read the impressive review article “Clozapine resistant schizophrenia: Newer avenues of management” with great enthusiasm and appreciation. The author believes that preventing clozapine resistance from developing may be the most effective treatment strategy for patients with clozapine-resistant schizophrenia (CRS), and optimizing clozapine treatment is a key component. Disentangling the differences between treatment-resistant schizophrenia and CRS is important for studies addressing treatment strategies for these difficult-to-treat populations. Baishideng Publishing Group Inc 2022-08-19 /pmc/articles/PMC9476841/ /pubmed/36158309 http://dx.doi.org/10.5498/wjp.v12.i8.1102 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letter to the Editor
Tseng, Ping-Tao
Chen, Mu-Hong
Liang, Chih-Sung
Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
title Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
title_full Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
title_fullStr Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
title_full_unstemmed Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
title_short Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
title_sort difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476841/
https://www.ncbi.nlm.nih.gov/pubmed/36158309
http://dx.doi.org/10.5498/wjp.v12.i8.1102
work_keys_str_mv AT tsengpingtao differencebetweentreatmentresistantschizophreniaandclozapineresistantschizophrenia
AT chenmuhong differencebetweentreatmentresistantschizophreniaandclozapineresistantschizophrenia
AT liangchihsung differencebetweentreatmentresistantschizophreniaandclozapineresistantschizophrenia

Ejemplares similares